Chemicals
Compare Stocks
5 / 10Stock Comparison
BAK vs TROX vs AVNT vs HUN vs EMN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
Chemicals - Specialty
Chemicals
Chemicals - Specialty
BAK vs TROX vs AVNT vs HUN vs EMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals | Chemicals | Chemicals - Specialty | Chemicals | Chemicals - Specialty |
| Market Cap | $637M | $1.41B | $3.38B | $2.60B | $8.42B |
| Revenue (TTM) | $73.77B | $2.92B | $3.28B | $5.69B | $8.64B |
| Net Income (TTM) | $-5.24B | $-359M | $158M | $-324M | $399M |
| Gross Margin | 4.4% | 5.8% | 31.7% | 12.9% | 19.8% |
| Operating Margin | -2.8% | -4.8% | 9.3% | -1.0% | 9.4% |
| Forward P/E | — | — | 12.1x | — | 11.6x |
| Total Debt | $73.72B | $3.59B | $1.92B | $2.73B | $5.08B |
| Cash & Equiv. | $14.99B | $211M | $511M | $429M | $566M |
BAK vs TROX vs AVNT vs HUN vs EMN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Braskem S.A. (BAK) | 100 | 35.8 | -64.2% |
| Tronox Holdings plc (TROX) | 100 | 132.8 | +32.8% |
| Avient Corporation (AVNT) | 100 | 148.9 | +48.9% |
| Huntsman Corporation (HUN) | 100 | 82.4 | -17.6% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BAK vs TROX vs AVNT vs HUN vs EMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BAK ranks third and is worth considering specifically for growth.
- 9.7% revenue growth vs EMN's -6.7%
TROX is the clearest fit if your priority is long-term compounding.
- 123.7% 10Y total return vs HUN's 59.2%
- +77.6% vs BAK's -6.6%
AVNT carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 0.6%, EPS growth -51.6%, 3Y rev CAGR -1.4%
- Lower volatility, beta 1.24, Low D/E 80.6%, current ratio 1.66x
- Beta 1.24, yield 2.9%, current ratio 1.66x
- 4.8% margin vs TROX's -12.3%
Among these 5 stocks, HUN doesn't own a clear edge in any measured category.
EMN is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 12 yrs, beta 1.32, yield 4.5%
- Better valuation composite
- 2.6% ROA vs TROX's -7.7%, ROIC 6.7% vs -0.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% revenue growth vs EMN's -6.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 4.8% margin vs TROX's -12.3% | |
| Stability / Safety | Beta 1.24 vs TROX's 2.38, lower leverage | |
| Dividends | 2.9% yield, 14-year raise streak, vs HUN's 5.7% | |
| Momentum (1Y) | +77.6% vs BAK's -6.6% | |
| Efficiency (ROA) | 2.6% ROA vs TROX's -7.7%, ROIC 6.7% vs -0.3% |
BAK vs TROX vs AVNT vs HUN vs EMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BAK vs TROX vs AVNT vs HUN vs EMN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVNT leads in 1 of 6 categories
TROX leads 1 • BAK leads 0 • HUN leads 0 • EMN leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVNT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BAK is the larger business by revenue, generating $73.8B annually — 25.3x TROX's $2.9B. AVNT is the more profitable business, keeping 4.8% of every revenue dollar as net income compared to TROX's -12.3%. On growth, TROX holds the edge at +3.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $73.8B | $2.9B | $3.3B | $5.7B | $8.6B |
| EBITDAEarnings before interest/tax | $2.7B | $166M | $445M | $160M | $1.2B |
| Net IncomeAfter-tax profit | -$5.2B | -$359M | $158M | -$324M | $399M |
| Free Cash FlowCash after capex | -$6.1B | -$275M | $205M | $135M | $498M |
| Gross MarginGross profit ÷ Revenue | +4.4% | +5.8% | +31.7% | +12.9% | +19.8% |
| Operating MarginEBIT ÷ Revenue | -2.8% | -4.8% | +9.3% | -1.0% | +9.4% |
| Net MarginNet income ÷ Revenue | -7.1% | -12.3% | +4.8% | -5.7% | +4.6% |
| FCF MarginFCF ÷ Revenue | -8.2% | -9.4% | +6.3% | +2.4% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -18.7% | +3.0% | +2.5% | +0.7% | -4.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +95.6% | +7.1% | +3.8% | -3.3% | -40.8% |
Valuation Metrics
Evenly matched — HUN and EMN each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 57% valuation discount to AVNT's 41.4x P/E. On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than HUN's 19.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $637M | $1.4B | $3.4B | $2.6B | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $12.5B | $4.8B | $4.8B | $4.9B | $12.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.64x | -2.97x | 41.45x | -9.41x | 17.96x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 12.05x | — | 11.63x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 5.59x |
| EV / EBITDAEnterprise value multiple | 12.99x | 17.03x | 12.32x | 19.79x | 8.96x |
| Price / SalesMarket cap ÷ Revenue | 0.04x | 0.49x | 1.04x | 0.46x | 0.96x |
| Price / BookPrice ÷ Book value/share | — | 0.96x | 1.42x | 0.87x | 1.41x |
| Price / FCFMarket cap ÷ FCF | — | — | 17.35x | 22.44x | 19.86x |
Profitability & Efficiency
Evenly matched — AVNT and EMN each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-30 for TROX. AVNT carries lower financial leverage with a 0.81x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), AVNT scores 5/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -30.4% | +6.6% | -8.1% | +6.7% |
| ROA (TTM)Return on assets | -5.6% | -7.7% | +2.6% | -4.6% | +2.6% |
| ROICReturn on invested capital | +1.5% | -0.3% | +3.9% | -0.6% | +6.7% |
| ROCEReturn on capital employed | +1.4% | -0.4% | +4.0% | -0.7% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 | 5 | 2 | 5 |
| Debt / EquityFinancial leverage | — | 2.48x | 0.81x | 0.92x | 0.84x |
| Net DebtTotal debt minus cash | $58.7B | $3.4B | $1.4B | $2.3B | $4.5B |
| Cash & Equiv.Liquid assets | $15.0B | $211M | $511M | $429M | $566M |
| Total DebtShort + long-term debt | $73.7B | $3.6B | $1.9B | $2.7B | $5.1B |
| Interest CoverageEBIT ÷ Interest expense | -0.25x | -1.16x | 5.02x | -1.08x | 2.22x |
Total Returns (Dividends Reinvested)
TROX leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVNT five years ago would be worth $7,949 today (with dividends reinvested), compared to $3,901 for BAK. Over the past 12 months, TROX leads with a +77.6% total return vs BAK's -6.6%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs BAK's -28.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +26.4% | +107.7% | +17.2% | +47.7% | +15.8% |
| 1-Year ReturnPast 12 months | -6.6% | +77.6% | +1.7% | +30.1% | -0.6% |
| 3-Year ReturnCumulative with dividends | -63.4% | -20.4% | +3.3% | -32.5% | +3.4% |
| 5-Year ReturnCumulative with dividends | -61.0% | -52.8% | -20.5% | -38.0% | -28.4% |
| 10-Year ReturnCumulative with dividends | +1.7% | +123.7% | +28.9% | +59.2% | +35.3% |
| CAGR (3Y)Annualised 3-year return | -28.4% | -7.3% | +1.1% | -12.3% | +1.1% |
Risk & Volatility
Evenly matched — AVNT and HUN each lead in 1 of 2 comparable metrics.
Risk & Volatility
AVNT is the less volatile stock with a 1.24 beta — it tends to amplify market swings less than TROX's 2.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 94.1% from its 52-week high vs BAK's 69.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.91x | 2.38x | 1.24x | 1.82x | 1.32x |
| 52-Week HighHighest price in past year | $5.29 | $10.59 | $44.85 | $15.89 | $84.18 |
| 52-Week LowLowest price in past year | $2.32 | $2.86 | $27.48 | $7.30 | $56.11 |
| % of 52W HighCurrent price vs 52-week peak | +69.7% | +83.3% | +82.3% | +94.1% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 48.9 | 40.6 | 47.7 | 60.6 | 50.2 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 3.1M | 621K | 6.2M | 1.5M |
Analyst Outlook
Evenly matched — AVNT and HUN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BAK as "Buy", TROX as "Buy", AVNT as "Buy", HUN as "Hold", EMN as "Buy". Consensus price targets imply 29.6% upside for AVNT (target: $48) vs -59.3% for BAK (target: $2). For income investors, HUN offers the higher dividend yield at 5.65% vs AVNT's 2.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $1.50 | $7.50 | $47.80 | $12.25 | $79.89 |
| # AnalystsCovering analysts | 6 | 17 | 20 | 33 | 35 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +3.4% | +2.9% | +5.7% | +4.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 14 | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.02 | $0.30 | $1.08 | $0.85 | $3.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.1% | +0.1% | +1.2% |
AVNT leads in 1 of 6 categories (Income & Cash Flow). TROX leads in 1 (Total Returns). 4 tied.
BAK vs TROX vs AVNT vs HUN vs EMN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BAK or TROX or AVNT or HUN or EMN a better buy right now?
For growth investors, Braskem S.
A. (BAK) is the stronger pick with 9. 7% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Braskem S. A. (BAK) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BAK or TROX or AVNT or HUN or EMN?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Avient Corporation at 41. 4x. On forward P/E, Eastman Chemical Company is actually cheaper at 11. 6x.
03Which is the better long-term investment — BAK or TROX or AVNT or HUN or EMN?
Over the past 5 years, Avient Corporation (AVNT) delivered a total return of -20.
5%, compared to -61. 0% for Braskem S. A. (BAK). Over 10 years, the gap is even starker: TROX returned +123. 7% versus BAK's +1. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BAK or TROX or AVNT or HUN or EMN?
By beta (market sensitivity over 5 years), Avient Corporation (AVNT) is the lower-risk stock at 1.
24β versus Tronox Holdings plc's 2. 38β — meaning TROX is approximately 91% more volatile than AVNT relative to the S&P 500. On balance sheet safety, Avient Corporation (AVNT) carries a lower debt/equity ratio of 81% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.
05Which is growing faster — BAK or TROX or AVNT or HUN or EMN?
By revenue growth (latest reported year), Braskem S.
A. (BAK) is pulling ahead at 9. 7% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Huntsman Corporation grew EPS -44. 5% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, AVNT leads at -1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BAK or TROX or AVNT or HUN or EMN?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -0. 7% for TROX. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BAK or TROX or AVNT or HUN or EMN more undervalued right now?
On forward earnings alone, Eastman Chemical Company (EMN) trades at 11.
6x forward P/E versus 12. 1x for Avient Corporation — 0. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 29. 6% to $47. 80.
08Which pays a better dividend — BAK or TROX or AVNT or HUN or EMN?
In this comparison, HUN (5.
7% yield), EMN (4. 5% yield), TROX (3. 4% yield), AVNT (2. 9% yield) pay a dividend. BAK does not pay a meaningful dividend and should not be held primarily for income.
09Is BAK or TROX or AVNT or HUN or EMN better for a retirement portfolio?
For long-horizon retirement investors, Avient Corporation (AVNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
24), 2. 9% yield). Braskem S. A. (BAK) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVNT: +28. 9%, BAK: +1. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BAK and TROX and AVNT and HUN and EMN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BAK is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock; AVNT is a small-cap quality compounder stock; HUN is a small-cap income-oriented stock; EMN is a small-cap deep-value stock. TROX, AVNT, HUN, EMN pay a dividend while BAK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.